Published in Gut on December 01, 1993
Endoscopic papillary large balloon dilation alone without sphincterotomy for the treatment of large common bile duct stones. BMC Gastroenterol (2011) 1.29
Percutaneous treatment of extrahepatic bile duct stones assisted by balloon sphincteroplasty and occlusion balloon. Korean J Radiol (2005) 1.22
Endoscopic management of difficult common bile duct stones. World J Gastroenterol (2013) 1.02
Open cholecystectomy in the age of the laparoscope. Ann R Coll Surg Engl (1995) 0.92
Endoscopic extraction of large common bile duct stones: A review article. World J Gastrointest Endosc (2012) 0.89
Endoscopic papillary large balloon dilation reduces the need for mechanical lithotripsy in patients with large bile duct stones: a systematic review and meta-analysis. Diagn Ther Endosc (2014) 0.85
Ampulla dilation with different sized balloons to remove common bile duct stones. World J Gastroenterol (2013) 0.83
Factors significantly contributing to a failed conventional endoscopic stone clearance in patients with "difficult" choledecholithiasis: a single-center experience. Diagn Ther Endosc (2014) 0.81
Quality indicators for ERCP. Am J Gastroenterol (2014) 0.81
Poorly expandable common bile duct with stones on endoscopic retrograde cholangiography. World J Gastroenterol (2012) 0.79
The effect of biliary stenting on difficult common bile duct stones. Prz Gastroenterol (2014) 0.77
Outcome of surgery for failed endoscopic extraction of common bile duct stones in elderly patients. Ann R Coll Surg Engl (1994) 0.76
Giant choledochal calculosis: surgical treatment. N Am J Med Sci (2014) 0.75
Benign retropneumoperitoneum developed after endoscopic sphincterotomy and large balloon dilation of biliary sphincter for removal of large biliary stones: a case report. Cases J (2008) 0.75
Randomised study on single stage laparo-endoscopic rendezvous (intra-operative ERCP) procedure versus two stage approach (Pre-operative ERCP followed by laparoscopic cholecystectomy) for the management of cholelithiasis with choledocholithiasis. J Minim Access Surg (2014) 0.75
Predictors for bile duct stone recurrence after endoscopic extraction for naïve major duodenal papilla: A cohort study. PLoS One (2017) 0.75
The European experience with laparoscopic cholecystectomy. Am J Surg (1991) 6.24
Early and late complications after endoscopic sphincterotomy for biliary lithiasis with and without the gall bladder 'in situ'. Gut (1984) 2.82
Endoscopic sphincterotomy for common bile duct calculi in patients with gall bladder in situ considered unfit for surgery. Gut (1988) 2.22
Endoscopic sphincterotomy for bile duct stones in patients with intact gallbladders. Br J Surg (1989) 1.73
Endoscopic stenting for long-term treatment of large bile duct stones: 2- to 5-year follow-up. Gastrointest Endosc (1987) 1.69
Study of common bile duct exploration and endoscopic sphincterotomy in a consecutive series of 438 patients. Br J Surg (1987) 1.45
Giant bile duct stones--non-surgical treatment. Endoscopy (1988) 1.45
Changing therapy for gallstone disease. N Engl J Med (1990) 1.17
Laserlithotripsy of common bile duct stones. Gut (1988) 0.99
Large bile duct stones treated by endoscopic biliary drainage. Surgery (1989) 0.97
Endoscopic papillotomy for removal of common bile duct stones without cholecystectomy. J R Coll Surg Edinb (1985) 0.95
Methyl-tert-butyl-ether for treating bile duct stones: the British experience. Br J Surg (1990) 0.86
Methyl tert butyl ether dissolution therapy for common bile duct stones. J Hepatol (1990) 0.86
Extracorporeal shock-wave lithotripsy of common bile duct stones. Gastroenterology (1989) 0.82
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Carcinoid tumour. Lancet (1998) 4.52
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut (2002) 4.01
Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther (2014) 3.98
Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev (2007) 2.75
Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol (2010) 2.50
Systematic review of randomized controlled trials on the effectiveness of virtual reality training for laparoscopic surgery. Br J Surg (2008) 2.43
Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J (1995) 2.39
Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg (2010) 2.38
Bacterial infection in the pathogenesis of variceal bleeding. Lancet (1999) 2.35
A prospective study of biliary cytology in 100 patients with bile duct strictures. Hepatology (1993) 2.34
The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant (2012) 2.29
An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy (2006) 2.22
Coagulation and fibrosis in chronic liver disease. Gut (2008) 2.22
Systematic review and meta-analysis of intraoperative versus preoperative endoscopic sphincterotomy in patients with gallbladder and suspected common bile duct stones. Br J Surg (2011) 2.13
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med (1983) 2.10
Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther (2006) 2.00
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet (1999) 1.98
"Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology (1998) 1.95
Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol (2002) 1.92
A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology (2002) 1.90
Cost-utility and value-of-information analysis of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg (2010) 1.88
An appraisal of the histopathological assessment of liver fibrosis. Gut (2006) 1.87
Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther (2005) 1.86
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet (1996) 1.78
A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol (1999) 1.76
Change in occurrence of paracetamol overdose in UK after introduction of blister packs. Lancet (2000) 1.75
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med (1992) 1.72
Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut (1998) 1.63
Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev (2006) 1.63
Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost (2010) 1.62
Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut (2006) 1.61
Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Am J Gastroenterol (1999) 1.60
Multidisciplinary approach to biliary complications of laparoscopic cholecystectomy. Br J Surg (1998) 1.59
Review article: portal vein thrombosis -- new insights into aetiology and management. Aliment Pharmacol Ther (2005) 1.59
Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology (1998) 1.57
Effect of liver blood flow and function on hepatic indocyanine green clearance measured directly in a cirrhotic animal model. Br J Surg (2000) 1.56
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study. Aliment Pharmacol Ther (2013) 1.56
Preoperative chemotherapy and the outcome of liver resection for colorectal metastases. World J Surg (2007) 1.52
Admission to medical school: from audit to action. J R Soc Med (1986) 1.52
Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil. Am J Transplant (2009) 1.52
Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol (1996) 1.49
Diurnal pattern of variceal bleeding in cirrhotic patients. J Hepatol (1993) 1.47
Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: poststudy surveillance to 3 years. Am J Transplant (2006) 1.47
Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis. Aliment Pharmacol Ther (2011) 1.46
Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther (2007) 1.45
Study of common bile duct exploration and endoscopic sphincterotomy in a consecutive series of 438 patients. Br J Surg (1987) 1.45
Genomic heterogeneity in synchronous hepatocellular carcinomas. Gut (1999) 1.44
LCAT activity as a prognostic liver function test. Lancet (1990) 1.43
Primary squamous carcinoma of liver: presentation as liver abscess. Indian J Gastroenterol (1998) 1.42
Meta-analysis of randomized controlled trials on the safety and effectiveness of day-case laparoscopic cholecystectomy. Br J Surg (2008) 1.40
Tacrolimus exposure after liver transplantation in randomized controlled trials: too much for too long. Am J Transplant (2013) 1.40
Peritoneal seeding of pancreatic head carcinoma following percutaneous transhepatic drainage and stenting. Br J Surg (1997) 1.40
Systematic review of radiological imaging for hepatocellular carcinoma in cirrhotic patients. Br J Radiol (2004) 1.40
Infection, coagulation, and variceal bleeding in cirrhosis. Gut (2005) 1.39
Staple-line erosion: a common source of recurrent bleeding following stapled oesophageal transection. Br J Surg (1991) 1.39
Electrophoretic and immunochemical analyses of the lipopolysaccharides from various strains of Aeromonas hydrophila. J Bacteriol (1985) 1.38
Ultrasound screening for hepatocellular carcinoma (HCC) in cirrhosis: the evidence for an established clinical practice. Clin Radiol (1998) 1.38
LeVeen shunt with wandering tip. Lancet (1991) 1.36
Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med (1982) 1.36
Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J Infect Dis (2004) 1.35
Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther (2009) 1.35
Controversies in the management of bleeding esophageal varices (1) N Engl J Med (1989) 1.30
Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology (1999) 1.29
Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol (1992) 1.27
Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias. Am J Transplant (2007) 1.25
Surface antigens of virulent strains of Aeromonas hydrophila. Vet Immunol Immunopathol (1986) 1.24
Bacteriuria and primary biliary cirrhosis. Gut (1984) 1.20
Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy. Am J Transplant (2012) 1.19
Donor-specific bone marrow infusion after orthotopic liver transplantation. Lancet (1994) 1.18
A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma. Br J Cancer (2013) 1.17
Management of colorectal liver metastases. Colorectal Dis (2003) 1.17
Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics. Aliment Pharmacol Ther (2006) 1.17
Structural and antigenic analysis of meningococcal piliation. Infect Immun (1985) 1.16
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther (2006) 1.15
Hepatic artery thrombosis after orthotopic liver transplantation: a review of nonsurgical causes. Liver Transpl (2001) 1.15
Should we biopsy each liver mass suspicious for HCC before liver transplantation?--no, please don't. J Hepatol (2005) 1.15
Distal spleno-renal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. A meta-analysis of 4 randomized clinical trials. J Hepatol (1992) 1.14
Controversies in the management of bleeding esophageal varices (2) N Engl J Med (1989) 1.14
In vivo demonstration of impaired microcirculation in steatotic human liver grafts. Liver Transpl Surg (1998) 1.14
Treatment of small hepatocellular carcinomas. Lancet (1992) 1.13
Incisional herniae following median sternotomy incisions: their incidence and aetiology. Br J Surg (1986) 1.13
Liver tumours due to endometriosis and endometrial stromal sarcoma. HPB (Oxford) (2002) 1.13
In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver (1997) 1.13
Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy. Eur J Surg Oncol (2009) 1.12
Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology (1995) 1.11
Oxidative-phosphorylation defects in liver of patients with Wilson's disease. Lancet (2000) 1.11
Effect of portal vein embolisation on the growth rate of colorectal liver metastases. Br J Cancer (2009) 1.10
Bleeding time in patients with hepatic cirrhosis. BMJ (1990) 1.10
Detection and speciation of Cryptosporidium spp. in environmental water samples by immunomagnetic separation, PCR and endonuclease restriction. J Med Microbiol (2000) 1.10
Hepatocellular ballooning after liver transplantation: a light and electronmicroscopic study with clinicopathological correlation. Histopathology (1991) 1.10